Nanoparticles are complex materials smaller than 100 nanometers, or about the size of a virus, but they have a large range of potential applications, from medicine to energy to electronics. Now, hundreds of new nanoparticles with previously unknown features have been produced using an innovative experimental approach.
This approach allowed them to discover novel nanoparticles, which combine many different materials in various arrangements. They then analyzed these nanoparticles to develop new guidelines that allowed them to make high-yield samples of the most interesting types of new nanoparticles.
Nanoparticles that can potentially be used to split water using sunlight, diagnose and treat cancer, and solve other important problems can be predicted and designed. These particles may need to include various types of semiconductors, catalysts, magnets, and other materials to function, all while maintaining strict requirements involving their size and shape.
“There are a certain number of rules that we and others have developed in this field that allow us to make a lot of different kinds of nanoparticles,” said Raymond Schaak, DuPont Professor of Materials Chemistry at Penn State and the leader of the research team.
“We can also predict, especially with the help of computers, tens of thousands of different nanoparticles that could be really interesting to study, but we have no clue how to make most of them. We need new rules that allow us to make nanoparticles with new properties, new functions, or new applications, and that allow us to better match the speed at which they can be predicted.”
The current set of rules, or design guidelines, available to researchers limits the variety of nanoparticles that they can produce, so the researchers set up experiments under unoptimized and previously unexplored conditions to see if they could make new types of particles that hadn’t previously been discovered.
“What we do can be described as ‘discovery without a target,'” said Connor R. McCormick, a graduate student in chemistry at Penn State and the first author of the paper.
“If you have a target in mind, you are trying to modulate the chemistry to make that target, but you need to know what factors to modulate—you need to know the rules—ahead of time. What is so exciting about our approach is that we are letting the chemistry guide us and show us what is possible. We can then characterize the products and discover what we can control in order to produce them intentionally.”
The researchers start with relatively simple rod-shaped nanoparticles composed of a single material, copper sulfide, which contains charged atoms (“cations”) of copper. They can then replace some or all of the copper in the particles with other metals using a process called “cation exchange.”
The arrangement of the metals in the particles and the interfaces between them determine the properties of the particles. Generally, this process is done one metal at a time using experimental conditions optimized to precisely control the cation exchange reaction. Here, in one experiment, the researchers added four different metal cations at the same time under conditions that were not optimized for any particular metal cation exchange. They then painstakingly characterized the resulting particles using electron microscopy and X-ray diffraction.
“Unlike most experiments, which are set up to converge on a single product, our goal was to set up the experiment in a way that maximized the diversity of nanoparticles that we produced,” said McCormick. “Of the 201 particles that we analyzed from one experiment, 102 were unique and many of them could not have been produced intentionally using existing design guidelines.”
The team then performed the experiment using slightly altered variables, changing the temperature of the reaction or the relative amount and variety of metal cations. By doing this, they produced even more complex nanoparticles and eventually were able to figure out the new rules that explained how the new types of nanoparticles had formed.
Finally, the team chose one of the new products and used the new design guidelines to efficiently produce it in larger quantities.
“Eventually, this approach could be used to screen for new particles with specific properties, but currently we are focusing on learning as much as we can about what all is possible to make,” said Schaak. “We’ve demonstrated that this exploratory approach can indeed help us to identify these ‘new rules’ and then use them to rationally produce new complex nanoparticles in high yield.”
The paper describing these experiments appears in the journal Nature Synthesis.
News
Cutting Two Amino Acids Slowed Prostate Cancer in Mice
A newly identified link between amino acid metabolism and cholesterol production may help prostate tumors adapt to hormone therapy. Prostate cancer can find ways around treatments designed to deprive tumors of the hormones they [...]
Largest-Ever Physics Survey Raises New Doubts About Our Model of the Universe
Physicists around the world remain deeply divided on key mysteries of the universe, from dark matter to quantum gravity. The standard cosmological model failed to gain majority support, and no leading theory dominated the [...]
Scientists Just Overturned a 100-Year-Old Belief About Bacteria in the Lungs
New findings raise questions about the role of microbes living in the lungs. More than 35 trillion bacteria live throughout the human body, forming microbiomes in the gut, mouth, lungs, skin, and urogenital tract. [...]
GHCE Concept
From the preface of the book Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artificial Intelligence, Edited by Frank Boehm: Since the publication of my first book (Nanomedical Device and Systems [...]
Novartis, Ionis drug failure spurs questions
Pelacarsen didn’t protect heart health despite lowering levels of a protein particle, “Lp(a),” in a large clinical trial — a result with important implications for cardiovascular drug research. Dive Brief: An RNA drug from [...]
New injectable treatment helps the brain rebuild after stroke
Biomedical engineers at Duke University have created an injectable biomaterial that may help the brain recover from damage left behind by an ischemic stroke. In experiments with mice, the material transformed the cavity created [...]
Scientists Discover a Hidden “Immune Organ” Inside the Skull
Researchers discovered lymph node-like immune hubs inside skull bone marrow that appear to act as rapid-response centers for the brain. For decades, the brain was thought to operate largely apart from the immune system. [...]
Engineered tRNAs and lipid nanoparticles target nonsense mutation cystic fibrosis
Researchers have developed a potential new approach for treating a form of cystic fibrosis caused by so-called nonsense mutations, combining chemically modified transfer RNAs with lipid nanoparticles designed to deliver the therapy directly to [...]
New pancreatic cancer drug carries a $39,800 monthly list price
A groundbreaking treatment for one of the most common forms of pancreatic cancer has been approved in pill form by the FDA. Revolution Medicines’ oral tablet daraxonrasib, branded as Rasonque, reduced the risk of [...]
Researchers Have Discovered a New Way To Reduce Chronic Nerve Pain
A cancer-linked protein called BRAF may help drive chronic nerve pain, and existing cancer drugs targeting it reduced pain sensitivity in preclinical models. Chronic nerve pain can persist long after an injury and often [...]
Our books now available worldwide!
Online Sellers other than Amazon, Routledge, and IOPP Indigo Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artifcial Intelligence Global Health Care Equivalency In The Age Of Nanotechnology, Nanomedicine And Artificial [...]
Quantum-Enabled Regenerative Health: Reimagining Wellness, Precision Health and Longevity Medicine
Introduction Healthcare is approaching a frontier where the quantum portfolio could influence not only how disease is diagnosed and treated, but how health itself is measured, modeled, predicted and preserved. Quantum computing, quantum simulation, [...]
FDA Clears First-of-Its-Kind Nonmedication Treatment for PTSD
The FDA has cleared a system that uses brain activity data to personalize magnetic stimulation for PTSD, adding a new nonmedication treatment option. Every day in the United States, approximately 17.5 veterans die by suicide, [...]
FDA approves breakthrough drug to treat advanced pancreatic cancer
The Food and Drug Administration (FDA) approved on Wednesday a drug that could extend the survival of those with metastatic pancreatic cancer. The drug, called daraxonrasib, will be sold under the brand name Rasonque [...]
AI Decodes a Hidden DNA Signal Linked to Disease-Causing Mutations
Machine learning identifies the likely “initiator” and enables new predictions about DNA mutations that can cause disease. Every human cell depends on tens of thousands of genes being switched on at the right time [...]
Pope Leo Urges Global Response to Congo’s Deadliest Ebola Outbreak
Pope Leo called for international action to address the Ebola outbreak in the Democratic Republic of Congo. The epidemic has claimed over 2,500 lives and is the nation's largest recorded outbreak. The Pope emphasized [...]















